StandardStandard

Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. / Shearer, James; Lynch, Thomas R; Chamba, Rampaul et al.
Yn: BJPsych open, Cyfrol 5, Rhif 5, 09.2019, t. e64.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Shearer, J, Lynch, TR, Chamba, R, Clarke, S, Hempel, RJ, Kingdon, DG, O'Mahen, H, Remington, B, Rushbrook, SC, Russell, IT, Stanton, M, Swales, M, Watkins, A, Whalley, B & Byford, S 2019, 'Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial', BJPsych open, cyfrol. 5, rhif 5, tt. e64. https://doi.org/10.1192/bjo.2019.57

APA

Shearer, J., Lynch, T. R., Chamba, R., Clarke, S., Hempel, R. J., Kingdon, D. G., O'Mahen, H., Remington, B., Rushbrook, S. C., Russell, I. T., Stanton, M., Swales, M., Watkins, A., Whalley, B., & Byford, S. (2019). Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. BJPsych open, 5(5), e64. https://doi.org/10.1192/bjo.2019.57

CBE

Shearer J, Lynch TR, Chamba R, Clarke S, Hempel RJ, Kingdon DG, O'Mahen H, Remington B, Rushbrook SC, Russell IT, et al. 2019. Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. BJPsych open. 5(5):e64. https://doi.org/10.1192/bjo.2019.57

MLA

VancouverVancouver

Shearer J, Lynch TR, Chamba R, Clarke S, Hempel RJ, Kingdon DG et al. Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial. BJPsych open. 2019 Medi;5(5):e64. Epub 2019 Gor 29. doi: 10.1192/bjo.2019.57

Author

Shearer, James ; Lynch, Thomas R ; Chamba, Rampaul et al. / Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy : findings of economic evaluation of RefraMED trial. Yn: BJPsych open. 2019 ; Cyfrol 5, Rhif 5. tt. e64.

RIS

TY - JOUR

T1 - Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy

T2 - findings of economic evaluation of RefraMED trial

AU - Shearer, James

AU - Lynch, Thomas R

AU - Chamba, Rampaul

AU - Clarke, Susan

AU - Hempel, Roelie J

AU - Kingdon, David G

AU - O'Mahen, Heather

AU - Remington, Bob

AU - Rushbrook, Sophie C

AU - Russell, Ian T.

AU - Stanton, Maggie

AU - Swales, Michaela

AU - Watkins, Alan

AU - Whalley, Ben

AU - Byford, Sarah

PY - 2019/9

Y1 - 2019/9

N2 - BACKGROUND: Refractory depression is a major contributor to the economic burden of depression. Radically open dialectical behaviour therapy (RO DBT) is an unevaluated new treatment targeting overcontrolled personality, common in refractory depression, but it is not yet known whether the additional expense of RO DBT is good value for money.AimsTo estimate the cost-effectiveness of RO DBT plus treatment as usual (TAU) compared with TAU alone in people with refractory depression (trial registration: ISRCTN85784627).METHOD: We undertook a cost-effectiveness analysis alongside a randomised trial evaluating RO DBT plus TAU versus TAU alone for refractory depression in three UK secondary care centres. Our economic evaluation, 12 months after randomisation, adopted the perspective of the UK National Health Service (NHS) and personal social services. It evaluated cost-effectiveness by comparing the net cost of RO DBT with the net gain in quality-adjusted life-years (QALYs), estimated using the EQ-5D-3L measure of health-related quality of life.RESULTS: The additional cost of RO DBT plus TAU compared with TAU alone was £7048 and was associated with a difference of 0.032 QALYs, yielding an incremental cost-effectiveness ratio (ICER) of £220 250 per QALY. This ICER was well above the National Institute for Health and Care Excellence (NICE) upper threshold of £30 000 per QALY. A cost-effectiveness acceptability curve indicated that RO DBT had a zero probability of being cost-effective compared with TAU at the NICE £30 000 threshold.CONCLUSIONS: In its current resource-intensive form, RO DBT is not a cost-effective use of resources in the UK NHS.Declaration of interestR.H. is co-owner and director of Radically Open Ltd, the RO DBT training and dissemination company. D.K. reports grants outside the submitted work from the National Institute for Health Research (NIHR). T.L. receives royalties from New Harbinger Publishing for sales of RO DBT treatment manuals, speaking fees from Radically Open Ltd, and a grant outside the submitted work from the Medical Research Council. He was co-director of Radically Open Ltd between November 2014 and May 2015 and is married to Erica Smith-Lynch, the principal shareholder and one of two directors of Radically Open Ltd. H.O'M. reports personal fees outside the submitted work from the Charlie Waller Institute and Improving Access to Psychological Therapy. S.R. provides RO DBT supervision through her company S C Rushbrook Ltd. I.R. reports grants outside the submitted work from NIHR and Health & Care Research Wales. M. Stanton reports personal fees outside the submitted work from British Isles DBT Training, Stanton Psychological Services Ltd and Taylor & Francis. M. Swales reports personal fees outside the submitted work from British Isles DBT Training, Guilford Press, Oxford University Press and Taylor & Francis. B.W. was co-director of Radically Open Ltd between November 2014 and February 2015.

AB - BACKGROUND: Refractory depression is a major contributor to the economic burden of depression. Radically open dialectical behaviour therapy (RO DBT) is an unevaluated new treatment targeting overcontrolled personality, common in refractory depression, but it is not yet known whether the additional expense of RO DBT is good value for money.AimsTo estimate the cost-effectiveness of RO DBT plus treatment as usual (TAU) compared with TAU alone in people with refractory depression (trial registration: ISRCTN85784627).METHOD: We undertook a cost-effectiveness analysis alongside a randomised trial evaluating RO DBT plus TAU versus TAU alone for refractory depression in three UK secondary care centres. Our economic evaluation, 12 months after randomisation, adopted the perspective of the UK National Health Service (NHS) and personal social services. It evaluated cost-effectiveness by comparing the net cost of RO DBT with the net gain in quality-adjusted life-years (QALYs), estimated using the EQ-5D-3L measure of health-related quality of life.RESULTS: The additional cost of RO DBT plus TAU compared with TAU alone was £7048 and was associated with a difference of 0.032 QALYs, yielding an incremental cost-effectiveness ratio (ICER) of £220 250 per QALY. This ICER was well above the National Institute for Health and Care Excellence (NICE) upper threshold of £30 000 per QALY. A cost-effectiveness acceptability curve indicated that RO DBT had a zero probability of being cost-effective compared with TAU at the NICE £30 000 threshold.CONCLUSIONS: In its current resource-intensive form, RO DBT is not a cost-effective use of resources in the UK NHS.Declaration of interestR.H. is co-owner and director of Radically Open Ltd, the RO DBT training and dissemination company. D.K. reports grants outside the submitted work from the National Institute for Health Research (NIHR). T.L. receives royalties from New Harbinger Publishing for sales of RO DBT treatment manuals, speaking fees from Radically Open Ltd, and a grant outside the submitted work from the Medical Research Council. He was co-director of Radically Open Ltd between November 2014 and May 2015 and is married to Erica Smith-Lynch, the principal shareholder and one of two directors of Radically Open Ltd. H.O'M. reports personal fees outside the submitted work from the Charlie Waller Institute and Improving Access to Psychological Therapy. S.R. provides RO DBT supervision through her company S C Rushbrook Ltd. I.R. reports grants outside the submitted work from NIHR and Health & Care Research Wales. M. Stanton reports personal fees outside the submitted work from British Isles DBT Training, Stanton Psychological Services Ltd and Taylor & Francis. M. Swales reports personal fees outside the submitted work from British Isles DBT Training, Guilford Press, Oxford University Press and Taylor & Francis. B.W. was co-director of Radically Open Ltd between November 2014 and February 2015.

U2 - 10.1192/bjo.2019.57

DO - 10.1192/bjo.2019.57

M3 - Article

C2 - 31352916

VL - 5

SP - e64

JO - BJPsych open

JF - BJPsych open

SN - 2056-4724

IS - 5

ER -